136886-13-0Relevant articles and documents
Biological evaluation of 4-aryl-1,4-dihydropyridines as VEGFR-2 kinase inhibitors
Sun,Ma,Yan
, p. 2891 - 2899 (2017/03/22)
Vascular endothelial growth factor-2 receptor (VEGFR-2) kinase is a promising target for the development of novel anticancer drugs. Molecular docking modeling was performed on a series of 4-aryl-1,4-dihydropyridines derivatives to evaluate the structural basis for VEGFR-2 inhibitory activity. Some 4-aryl-1,4-dihydropyridines were synthesized in the reaction of aromatic aldehydes and ethyl propiolate with anilines in acetic acid. The biological activities were evaluated against the cells A549, A431 and Hep-G2. The results indicated that 4-aryl-1,4-dihydropyridines could be the promising potential VEGFR-2 inhibitors.
Catalytic synthesis of 1,4-dihydropyridine derivatives using scandium(III) triflate
Kikuchi, Satoshi,Iwai, Masahiro,Murayama, Hiroyuki,Fukuzawa, Shin-ichi
, p. 114 - 116 (2008/04/13)
Scandium(III) triflate smoothly catalyzed the reaction of imines with ethyl propiolate (2.5 equiv) to produce the corresponding N-substituted 1,4-dihydropyridines in good yields in toluene or BTF under reflux conditions. It also catalyzed the reaction of
SYNTHESIS AND ELECTROCHEMICAL OXIDATION OF 1-ARYL-3,5-DIETHOXYCARBONYL-2,6-UNSUBSTITUTED 1,4-DIHYDROPYRIDINES
Chekavichus, B. S.,Sausin'sh, A. E.,Kadysh, V. P.,Dubur, G. Ya.,Stradyn', Ya. P.
, p. 302 - 306 (2007/10/02)
The possibility of obtaining 1-aryl-3,5-diethoxycarbonyl-2,6-unsubstituted 1,4-dihydropyridines with electron-acceptor substituents in the N-phenyl radical was demonstrated.The intermediate products of their formation, viz., 2,4-bis(arylaminomethylene)-3-